Is Risperdal Approved for Bipolar Disorder?
Yes, Risperdal (risperidone) is FDA-approved for treating bipolar disorder in adults and children aged 10 and older. It addresses acute manic or mixed episodes, either alone or with lithium or valproate. The approval stems from clinical trials showing it reduces manic symptoms like elevated mood and irritability [1][2].
How Does Risperdal Work for Bipolar?
Risperdal is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2 receptors in the brain, helping stabilize mood swings in bipolar mania. It does not treat depressive episodes directly but prevents relapse when used long-term after mania [1][3].
What Dosages Are Used for Bipolar?
Typical starting dose for adults is 2-3 mg daily, titrated up to 1-6 mg based on response. For adolescents (10-17), it starts at 0.5 mg daily, up to 2.5 mg. It's taken orally as tablets, solution, or disintegrating tabs, often split into morning/evening doses [1][4].
Common Side Effects in Bipolar Patients
Patients report weight gain (up to 20% increase), drowsiness, elevated prolactin (leading to breast enlargement or missed periods), tremors, and metabolic changes like high blood sugar. Long-term use raises risks of tardive dyskinesia or diabetes. Monitoring includes blood tests for glucose and lipids [1][2][5].
How Does Risperdal Compare to Other Bipolar Treatments?
| Drug | Key Use in Bipolar | Common Differences from Risperdal |
|------|---------------------|-----------------------------------|
| Lithium | Mania prevention, depression | Better for long-term maintenance; fewer metabolic risks but requires blood monitoring |
| Quetiapine (Seroquel) | Mania and depression | Also treats bipolar depression; more sedating, less prolactin elevation |
| Olanzapine (Zyprexa) | Acute mania | Similar efficacy but higher weight gain risk |
| Aripiprazole (Abilify) | Maintenance | Partial agonist; less weight gain, more activation |
Risperdal matches efficacy in mania trials but has a higher extrapyramidal symptom risk than some peers [3][6].
Off-Label Uses and Limitations
Risperdal treats schizophrenia and autism irritability on-label but is used off-label for bipolar depression or maintenance. It's not first-line for depression phases, where mood stabilizers like lamotrigine are preferred. Black-box warnings cover increased death risk in elderly dementia patients and metabolic issues [1][2].
Who Makes Risperdal and When Do Patents Expire?
Janssen (Johnson & Johnson) developed Risperdal, approved in 1993. The main composition patent (U.S. 4,804,663) expired in 2007, enabling generics. Remaining pediatric exclusivity ended in 2008. Check DrugPatentWatch.com for latest litigation on formulations or methods [7].
Sources
[1]: FDA Label for Risperdal
[2]: NIMH Bipolar Treatments
[3]: PubMed: Risperidone in Bipolar (Yatham 2003)
[4]: UpToDate: Risperidone Dosing
[5]: Drugs.com Side Effects
[6]: Cochrane Review: Antipsychotics in Bipolar
[7]: DrugPatentWatch: Risperdal